Latest News about PHVS
Recent news which mentions PHVS
PHVS Stock Earnings: Pharvaris Beats EPS for Q2 2024
August 14, 2024
Tickers
PHVS
From InvestorPlace
Tickers
PHVS
From InvestorPlace
PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023
April 10, 2024
Tickers
PHVS
From InvestorPlace
FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps
January 22, 2024
From Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
From Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
From Benzinga
Turnaround For Pharvaris Since FDA Clinical Hold - Data Shows Its Oral Hereditary Angioedema Treatment Cuts Attacks
December 06, 2023
Tickers
PHVS
From Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
December 06, 2023
From Benzinga
From InvestorPlace
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
From Benzinga
Shopify (SHOP) Stock Falls Following Analyst Downgrade
December 06, 2023
From InvestorPlace
Why Is Pharvaris (PHVS) Stock Up 36% Today?
December 06, 2023
From InvestorPlace
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
From Benzinga
Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside
September 25, 2023
Tickers
PHVS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
From Benzinga
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
From Benzinga
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
August 18, 2023
From Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
From Benzinga
From Benzinga
From InvestorPlace
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 24, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.